Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research Interest Keywords
- antimicrobial resistance
- antibiotics
- microbiology
- infections
- Diagnostics
- gram-negative bacteria
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Assessment of the infectious diseases pharmacist workforce across the U.S.
Hirsch, E. B. (PI), Gaither, C. A. (CoI), Nicol, M. R. (CoI) & Schommer, J. C. (CoI)
SOC OF INFECTIOUS DISEASES PHARMACISTS
1/17/23 → 4/30/26
Project: Research project
-
Optimal vancomycin exposure target for pulmonary exacerbations in CF
Illamola, S. M. (PI), Billings, J. L. (CoI), Evans, M. D. (CoI) & Hirsch, E. B. (CoI)
1/1/21 → 12/31/23
Project: Research project
-
Activity of ceftolozane/tazobactam and ceftazidime/aviba
Hirsch, E. B. (PI)
1/15/18 → 5/10/20
Project: Research project
-
A Retrospective Multi-Center Study to Assess Patient Out
Hirsch, E. B. (PI)
7/1/17 → 12/31/20
Project: Research project
-
A urinalysis to urine culture reflex protocol results in high rates of asymptomatic bacteriuria treatment
Zheng, D., Hamid, L., Bixby, M. L. & Hirsch, E. B., Sep 12 2025, In: Antimicrobial Stewardship and Healthcare Epidemiology. 5, 1, e213.Research output: Contribution to journal › Article › peer-review
Open Access -
Development and implementation of the ASHP Midyear Travel Award to support racially and ethnically minoritized pharmacy students
Abdul-Mutakabbir, J. C., Saunders, I. M., Bandali, A., Ko, C. L., Nussbaum, B. B., Brown, S. D. & Hirsch, E. B., Mar 15 2025, In: American Journal of Health-System Pharmacy. 82, 6, p. 257-264 8 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Evaluation of cefazolin <3 g vs. 3 g treatment doses for cellulitis in patients who weigh ≥120 kg within a large, community health system via modified desirability of outcomes ranking (DOOR) methodology
Gens, K. D., Gagnon, B. R., Claeys, K. C., Wankum, M. A. & Hirsch, E. B., Dec 2025, In: Journal of Infection and Chemotherapy. 31, 12, 102833.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Heteroresistance associated with the production of fosfomycin-resistant inner colonies during disk diffusion testing among a geographically diverse collection of Klebsiella pneumoniae clinical isolates
Bixby, M. L., Collins, L. B., Daley, E. C., Salay, J. M., Oliver, S., Bryson, A. L. & Hirsch, E. B., Feb 1 2025, In: JAC-Antimicrobial Resistance. 7, 1, dlaf013.Research output: Contribution to journal › Article › peer-review
Open Access -
Into the Unknown: Practical Remdesivir Restriction in the Era of Widespread SARS-CoV-2 Seropositivity
Christensen, A., Nelson, Z., Gustafson, S., Stoecker, R., Footer, B., Trower, N., Johnson, L. G., Hirsch, E. B., Collinet-Adler, S., Enzmann, M., Ryberg, E. & Peglow, S. R., Oct 15 2025, In: Clinical Infectious Diseases. 81, 4, p. 738-747 10 p.Research output: Contribution to journal › Article › peer-review
Press/Media
-
Bacteria “Tolerant” of One Antibiotic Are More Likely to Develop Resistance
1/9/20
1 Media contribution
Press/Media: Expert Comment or Interview